GlucoTrack (GCTK) Insider Trading & Ownership $0.15 +0.00 (+1.38%) As of 09:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GlucoTrack (NASDAQ:GCTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage46.50%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$229,950.00Number OfInsiders Selling(Last 3 Years)0 Get GCTK Insider Trade Alerts Want to know when executives and insiders are buying or selling GlucoTrack stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GCTK Insider Buying and Selling by Quarter GlucoTrack Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/22/2024Drew SycoffDirectorBuy1,825$126.00$229,950.00 (Data available from 1/1/2013 forward) GCTK Insider Trading Activity - Frequently Asked Questions Who is on GlucoTrack's Insider Roster? The list of insiders at GlucoTrack includes Drew Sycoff. Learn more on insiders at GCTK. What percentage of GlucoTrack stock is owned by insiders? 46.50% of GlucoTrack stock is owned by insiders. Learn more on GCTK's insider holdings. Which GlucoTrack insiders have been buying company stock? The following insider purchased GCTK shares in the last 24 months: Drew Sycoff ($229,950.00). How much insider buying is happening at GlucoTrack? Insiders have purchased a total of 1,825 GCTK shares in the last 24 months for a total of $229,950.00 bought. GlucoTrack Key ExecutivesMr. Paul V. Goode Ph.D. (Age 55)Chief Executive Officer Compensation: $225kMr. Mark Tapsak Ph.D. (Age 55)Vice President of Technology Compensation: $165kMs. Drinda Benjamin (Age 48)Vice President of Marketing Mr. James P. Thrower Ph.D. (Age 54)Vice President of Engineering Compensation: $230kMr. Avner Gal MBA (Age 70)MSc.EE, Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board Compensation: $187.39kMr. David Malka BA (Age 59)Co-Founder Compensation: $191.86kMr. James S. Cardwell (Age 63)Chief Financial Officer More Insider Trading Tools from MarketBeat Related Companies ReWalk Robotics Insider Transactions SeaStar Medical Insider Transactions PAVmed Insider Transactions Co-Diagnostics Insider Transactions Allurion Technologies Insider Transactions Plus Therapeutics Insider Transactions STRATA Skin Sciences Insider Transactions Predictive Oncology Insider Transactions Intelligent Bio Solutions Insider Transactions Sintx Technologies Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:GCTK) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GCTK Stock Free GCTK Stock Alerts